Catalyst Wire Dossier Catalyst Wire Dossier

VAK694

· Novartis
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VAK694, covering 2010-09-27 to 2020-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis [Phase 2]

See pricing